AmerisourceBergen Inks 10 year Distribution Deal with Drugsellers

Related tags Pharmacology

The long-term distribution deal with Walgreens and Alliance Boots is expected to add an incremental $28 billion in revenues, according to AmerisourceBergen.

The pharmaceutical services company has announced the deal will expand its existing relationships with the companies and includes a ten-year comprehensive primary pharmaceutical distribution contract with Walgreens and access to generic drugs and related pharmaceutical products through a joint venture between Walgreens and Boots Alliance.

CEO of AmerisourceBergen, Steven Collis, said in an official statement the company has “entered into a unique opportunity to unlock value in the pharmaceutical supply chain by collaborating to leverage all of our proven strengths.”

“This new relationship will significantly strengthen and grow our core business,”​ he continued, adding: “These agreements not only expand our U.S. business, but also provide opportunities to meaningfully grow our specialty and manufacturer services businesses internationally.”

The distribution contract will commence in September with branded pharmaceuticals and AmerisourceBergen is expected to takeover the distribution of Walgreen’s generics from 2014.

According to AmerisourceBergen - who last year purchased logistics company World Courier​ for $520m - this deal will utilize unused capacity in its current distribution network.

Related news

Show more

Related products

show more

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

cGMP Assurance of Supply Services Case Study

cGMP Assurance of Supply Services Case Study

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Apr-2023 | Case Study

Having the right raw materials available for production when they’re needed is imperative, as delays can negatively impact production schedules. Manufacturers...

Designing an Optimal APAC Clinical Supply Chain

Designing an Optimal APAC Clinical Supply Chain

Content provided by Catalent | 08-Mar-2023 | Infographic

With clinical study activity increasing across the Asia-Pacific region, it is important for sponsors—both in APAC and globally—to understand the broader...

Enhance your cGMP chemical supply chain

Enhance your cGMP chemical supply chain

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 09-Feb-2023 | White Paper

Supply chain issues have real, quantifiable impacts on biomanufacturers. However, the right support can make a cGMP supply chain operate seamlessly. Thermo...

Related suppliers

Follow us

Products

View more

Webinars